Skip Navigation



Carcinogenesis Advance Access published online on December 20, 2006
Carcinogenesis, doi:10.1093/carcin/bgl253
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
28/3/507    most recent
bgl253v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schwartz, A. G.
Right arrow Articles by Cote, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, A. G.
Right arrow Articles by Cote, M. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The Molecular Epidemiology of Lung Cancer

Ann G. Schwartz, Geoffrey M. Prysak, Cathryn H. Bock and Michele L. Cote

Population Studies and Prevention Program, Karmanos Cancer Institute and Department of Internal Medicine, Wayne State University School of Medicine

Address correspondence to: Dr. Ann G. Schwartz, Karmanos Cancer Institute, 110 E. Warren Avenue, Detroit, MI 48103, Phone: (313) 833-0715 ext. 2024, Fax: (313) 833-7806, e-mail: schwarta{at}karmanos.org

Lung cancer is the leading cause of cancer mortality worldwide. There have been only slight improvements in early diagnosis and survival reflecting limited advances in screening and treatment for lung cancer. The identification of host differences in susceptibility to lung carcinogens, in particular to cigarette smoke, is essential in predicting who is at highest risk. Susceptibility differences in the form of rare, high penetrance genes are suggested from studies of familial aggregation of lung cancer and a linkage study. Studies focused on more common, low penetrance genes in the tobacco smoke metabolism pathways (phase I and phase II enzymes) and DNA repair pathways are reviewed, as are inflammation and cell cycle-related genes and DNA adducts as intermediate biomarkers. Also reviewed are studies of epigenetic mechanisms, such as methylation, as alternative sources of variation in host susceptibility. Studies of molecular epidemiology in lung cancer survival are discussed briefly. In the future, studies that focus on complex interactions between multiple genes and environmental exposures within pertinent pathways are needed. New technological advances in genotyping will help move the field forward.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
E. Taioli
Gene-environment interaction in tobacco-related cancers
Carcinogenesis, August 1, 2008; 29(8): 1467 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. S. Hecht, P. W. Villalta, and J.B. Hochalter
Analysis of phenanthrene diol epoxide mercapturic acid detoxification products in human urine: relevance to molecular epidemiology studies of glutathione S-transferase polymorphisms
Carcinogenesis, May 1, 2008; 29(5): 937 - 943.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Kong, X. Wang, W. Xu, S. Behera, G. Hellermann, A. Kumar, R. F. Lockey, S. Mohapatra, and S. S. Mohapatra
Natriuretic Peptide Receptor A as a Novel Anticancer Target
Cancer Res., January 1, 2008; 68(1): 249 - 256.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E.L. Crawford, T. Blomquist, D.N. Mullins, Y. Yoon, D.R. Hernandez, M. Al-Bagdhadi, J. Ruiz, J. Hammersley, and J.C. Willey
CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions
Carcinogenesis, December 1, 2007; 28(12): 2552 - 2559.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. Paleari, P. Granone, A. Grozio, A. Cesario, and P. Russo
Commentary: Early Diagnosis of Lung Cancer: Where Do We Stand?
Oncologist, December 1, 2007; 12(12): 1433 - 1436.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.